New psoriasis drug effective for three-quarters of patients in clinical trial

Two Phase 3 clinical trials have shown that tildrakizumab is effective and well-tolerated in patients with moderate-to-severe chronic plaque psoriasis.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news